πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 110 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 8481738

Gonadotropin-releasing hormone receptor antagonists and methods relating thereto

Neurocrine Biosciences, Inc. Β· Granted Tue Jul 09 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 04 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8357697

Substituted 3-isobutyl-9,10-dimethoxy-1,3,4,6,7,11b-hexahydro-2H-pyrido[2,1-A]isoquinolin-

Neurocrine Biosciences, Inc. Β· Granted Tue Jan 22 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 17 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8293729

Compounds, pharmaceutical composition and methods relating thereto

Neurocrine Biosciences, Inc. Β· Granted Tue Oct 23 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 18 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8263588

Gonadotropin-releasing hormone receptor antagonists and methods relating thereto

Neurocrine Biosciences, Inc. Β· Granted Tue Sep 11 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 06 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8084614

Gonadotropin-releasing hormone receptor antagonists and methods relating thereto

Neurocrine Biosciences, Inc. Β· Granted Tue Dec 27 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 22 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8039627

Substituted 3-isobutyl-9,10-dimethoxy-1,3,4,6,7,11b-hexahydro-2H-pyrido[2,1-A]isoquinolin-

Neurocrine Biosciences, Inc. Β· Granted Tue Oct 18 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 13 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7652035

CRF receptor antagonists and methods relating thereto

Neurocrine Biosciences, Inc. Β· Granted Tue Jan 26 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 21 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7462625

Gonadotropin-releasing hormone receptor antagonists and methods relating thereto

Neurocrine Biosciences, Inc. Β· Granted Tue Dec 09 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 04 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7459458

Polymorph of N-methyl-N-(3-{3-[2-thienylcarbonyl]-pyrazol-[1,5-Ξ±]-pyrimidin-7-yl}phenyl)ac

Neurocrine Biosciences, Inc. Β· Granted Tue Dec 02 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 27 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7427630

Condensed N-heterocyclic compounds and their use as CRF receptor antagonists

Neurocrine Biosciences, Inc. Β· Granted Tue Sep 23 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 18 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7419983

Gonadotropin-releasing hormone receptor antagonists and methods related thereto

Neurocrine Biosciences, Inc. Β· Granted Tue Sep 02 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 28 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7378552

Monoamine re-uptake inhibitors and methods relating thereto

Neurocrine Biosciences, Inc. Β· Granted Tue May 27 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 22 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7329669

Gonadotropin-releasing hormone receptor antagonists and methods relating thereto

Neurocrine Biosciences, Inc. Β· Granted Tue Feb 12 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 07 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7304069

Hydrate of N-methyl-N-(3-{3-[2-thienylcarbonyl]-pyrazol-[1,5Ξ±]-pyrimidin-7-yl}phenyl)aceta

Neurocrine Biosciences, Inc. Β· Granted Tue Dec 04 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 29 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7229995

Gonadotropin-releasing hormone receptor antagonists and methods relating thereto

Neurocrine Biosciences, Inc. Β· Granted Tue Jun 12 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 07 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7179815

Gonadotropin-releasing hormone receptor antagonists and methods relating thereto

Neurocrine Biosciences, Inc. Β· Granted Tue Feb 20 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 15 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7176211

Gonadotropin-releasing hormone receptor antagonists and methods relating thereto

Neurocrine Biosciences, Inc. Β· Granted Tue Feb 13 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 08 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7081459

Gonadotropin-releasing hormone receptor antagonists and methods relating thereto

Neurocrine Biosciences, Inc. Β· Granted Tue Jul 25 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 20 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7071200

Gonadotropin-releasing hormone receptor antagonists and methods relating thereto

Neurocrine Biosciences, Inc. Β· Granted Tue Jul 04 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 29 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7056927

Gonadotropin-releasing hormone receptor antagonists and methods relating thereto

Neurocrine Biosciences, Inc. Β· Granted Tue Jun 06 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 01 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7034118

Corticotropin-releasing factor2 receptors

Neurocrine Biosciences, Inc. Β· Granted Tue Apr 25 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 20 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 7015226

Gonadotropin-releasing hormone receptor antagonists and methods relating thereto

Neurocrine Biosciences, Inc. Β· Granted Tue Mar 21 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 16 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6958342

Polymorphs of N-methyl-N-(3-{3-[2-thienylcarbonyl]-pyrazol-[1,5-Ξ±]-pyrimidin-7-yl}phenyl)a

Neurocrine Biosciences, Inc. Β· Granted Tue Oct 25 2005 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 20 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6951858

Gonadotropin-releasing hormone receptor antagonists and methods relating thereto

Neurocrine Biosciences, Inc. Β· Granted Tue Oct 04 2005 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 29 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

expired